Intelligent Bio Solutions Inc.

13F holders, Q1 2025 (March 31)
9holders +1
4new positions
3sold out
$1.44avg. 13F price*

At the end of Q1 2025, 9 institutions reported holding Intelligent Bio Solutions Inc. in their 13F filings, up 1 from Q4 2024. 4 opened new positions and 3 sold out. The largest holders were Alyeska Investment Group, L.P. ($884K), Altium Capital Management LLC ($215K) and Geode Capital Management, LLC ($71K).

Company
Intelligent Bio Solutions Inc.
CUSIP
36151G600
Latest filing quarter
Q3 2025

History

Number of 13F holders

051015 Q1 2024: 14Q1 2024Q2 2024: 8Q2 2024Q3 2024: 8Q3 2024Q4 2024: 8Q4 2024Q1 2025: 9Q1 2025Q2 2025: 9Q2 2025Q3 2025: 12Q3 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions4$1.2M
Exits3$44K

All 13F filers, Q4 2024 → Q1 2025: 833,868 shares bought and 33,528 shares sold, net +800,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

Alyeska Investment Group, L.P. 0.00% New 613,892 $884K
Altium Capital Management LLC 0.62% New 149,252 $215K
Geode Capital Management, LLC 0.00% Add +84.3% 49,012 $71K
Susquehanna International Group, LLP 0.00% New 35,487 $51K
Vanguard Group Inc. 0.00% No change 15,485 $22K
Goldman Sachs Group Inc. 0.00% New 12,817 $18K
UBS Group AG 0.00% Reduce -59.6% 1,172 $2K
Bank of America Corp. 0.00% Add +25.0% 45 $65
SBI Securities Co., Ltd. 0.00% Reduce -99.5% 1 $1

"% of holder's portfolio" is INTELLIGENT BIO SOLUTIONS IN's weight in each manager's 13F, not the share of Intelligent Bio Solutions Inc. the manager owns.